Cargando…
Cilostazol increases patency and reduces adverse outcomes in percutaneous femoropopliteal revascularisation: a meta-analysis of randomised controlled trials
BACKGROUND: Cilostazol is an oral antiplatelet agent currently indicated for treatment of intermittent claudication. There is evidence that cilostazol may reduce femoropopliteal restenosis after percutaneous endovascular intervention. METHODS: We searched PubMed, Scopus and Cochrane databases from 1...
Autores principales: | Benjo, Alexandre M, Garcia, Daniel C, Jenkins, J Stephen, Cardoso, Rhanderson M N, Molina, Taina P, El-Hayek, Georges E, Nadkarni, Girish N, Aziz, Emad F, Dinicolantonio, James J, Collins, Tyrone |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225296/ https://www.ncbi.nlm.nih.gov/pubmed/25392738 http://dx.doi.org/10.1136/openhrt-2014-000154 |
Ejemplares similares
-
Systematic oral hydration with water is similar to parenteral hydration for prevention of contrast-induced nephropathy: an updated meta-analysis of randomised clinical data
por: Agarwal, Shiv Kumar, et al.
Publicado: (2015) -
Endovascular revascularization strategies for aortoiliac and femoropopliteal artery disease: a meta-analysis
por: Koeckerling, David, et al.
Publicado: (2023) -
Coronary revascularisation in patients with chronic kidney disease and end‐stage renal disease: A meta‐analysis
por: Li, Xihui, et al.
Publicado: (2021) -
Incidence of cardiovascular events and gastrointestinal bleeding in patients receiving clopidogrel with and without proton pump inhibitors: an updated meta-analysis
por: Cardoso, Rhanderson N, et al.
Publicado: (2015) -
The patency of graft and anastomoses in sequential and individual coronary artery bypass grafting: A meta-analysis
por: Li, Yongxing, et al.
Publicado: (2020)